ESM-1 is a biomarker associated with tumor progression in various types of tumors, including lung, liver, brain, kidney, and stomach tumors, and ESM-1 overexpression has been associated with poor prognosis [7–11]. This evidence concerns the gene ESM1 and gastric neoplasm.